Clinical Trial Update: FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing FEIBA reconstitution volume reduction and faster infusion in patients with hemophilia A or B with inhibitors; study completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia or with Inhibitors

Drugs mentioned

• FEIBA (activated prothrombin complex concentrate)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A or B With Inhibitors | Phase 3 | Status: COMPLETED | Results posted: 2023-02-09